Cardiac electrophysiologist Dr. Jonathan Piccini says Medtronic's Define AFib study offers important lessons for other device ...
Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...
The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.
Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...
Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has ...
It's an honor to be a part of this process to, as a basic scientist, be able to play a small role in improving the lives of ...
The brain implants market is projected to grow from US$ 7.21 billion in 2022 to US$ 17.65 billion by 2030, at a CAGR of 11.8% ...
Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first patient implants.
BrainSense™ Adaptive DBS is available to Medtronic DBS patients with Parkinson's who have been implanted with a Percept™ neurostimulator, as well as future Medtronic DBS patients. With more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback